-
Pfizer P drug medical insurance negotiation out, can China forcibly imitate
Time of Update: 2023-02-02
After the Paxlovid medical insurance negotiations were out, the long-dormant "patent compulsory license" once again became a hot spot in the society, and some medical and legal professionals called fo
-
Another batch of pharmaceutical companies announced fundraising projects, mainly focusing on new drug research and development and other fields
Time of Update: 2023-02-01
279 billion yuan after the IPO of Xintong Drug Science and Technology Innovation Board, of which 900 million yuan will be used for new drug research and development projects, 180 million yuan will be used for innovative drug industrialization production base construction projects, and 200 million yuan will be used for supplementary working capital projects.
-
Under the adjustment of the medical insurance catalogue, these two major drug markets will usher in new development opportunities
Time of Update: 2022-10-25
Among them, there is no time limit for "approval for marketing after January 1, 2017" for the declaration conditions for rare disease drugs, and drugs included in the national list of encouraged generic drugs and encouraged research and development to apply for children's drugs can be declared in this year's medical insurance catalogue.
-
Nature: After more than 20 years, the first physical connection map of the human immune system was successfully drawn
Time of Update: 2022-09-09
Using SAVEXIS, the researchers systematically mapped direct protein interactions across a recombinant library containing most of the surface proteins detectable on human immune cells .
Using SAVEXIS, the researchers systematically mapped direct protein interactions across a recombinant library containing most of the surface proteins detectable on human immune cells .
-
Give full play to the advantages of food and drug homologous products in Guangxi to promote industry revitalization and people's health - the establishment of a demonstration base in Guangxi (Nanning
Time of Update: 2022-08-31
In the post-pandemic era, health has become our common priority . With the improvement of people's material living standards, people not only pursue to eat well and eat well, but also pursue healthy
-
Novartis leukemia therapy starts phase 3 clinical trial in China and just got approval in the US
Time of Update: 2022-02-26
TextPharmaceutical GuanlanOn November 15, the China Drug Clinical Trial Registration and Information Publicity Platform revealed that Novartis has initiated Phase 3 treatment of ABL001 in newly diagnosed Philadelphia (Ph) chromosome-positive chronic myeloid leukemia (CML) adult patients in the chronic phase in China.
-
The State Food and Drug Administration held a symposium on promoting the comprehensive revitalization of Northeast China
Time of Update: 2022-01-24
On the afternoon of January 13, the State Food and Drug Administration held a symposium on promoting the comprehensive revitalization of the Northeast, implementing the "14th Five-Year Plan for the C
-
Announcement of the State Food and Drug Administration on Revising the Instructions for Ginkgo Damo Injection (No. 71 of 2021
Time of Update: 2021-11-14
The marketing authorization holder of this product should submit a supplementary application for the revision of the insert in accordance with the requirements for the revision of the insert sheet of Ginkgo Damo injection in accordance with the "Administrative Measures for Drug Registration" and other relevant regulations.
-
Is the drop in platelets really caused by drugs
Time of Update: 2021-11-03
On February 18, the clinical round showed that the continued decline of platelets was considered a serious infection, and the possibility of drug causes could not be ruled out .
-
Haisco submits a marketing application for the fourth indication of cyclopofol injection
Time of Update: 2021-08-10
On June 30, Haisco issued an announcement stating that its innovative drug cyclopofol injection for the indication of "general anesthesia induction and maintenance" has been recently accepted by the Drug Evaluation Center of the China National Medical Products Administration .
-
Lingbei meets its rivals
Time of Update: 2021-08-02
According to data from Meinenet, in 2020, the total sales of vothiaxetine hydrobromide tablets in the terminals of Chinese public medical institutions and the terminals of Chinese urban physical pharmacies exceed 80 million yuan, and there is only one manufacturer in Lingbei .
-
The Guangdong Super League is coming
Time of Update: 2021-07-27
According to the previous information flowing out of the industry, Guangdong is in Shanxi, Fujian, Jiangxi, Henan, Hubei, Hunan, Guangxi, Hainan, Guizhou, Yunnan, Shaanxi, Gansu, Qinghai, Ningxia, Xinjiang, and Xinjiang Construction Corps in 16 provinces (autonomous regions, corps) An invitation was issued to form a regional group purchasing alliance to jointly carry out mass procurement of 281 drugs .
-
Jingxin Pharmaceutical Memantine Hydrochloride Sustained Release Capsules Obtained Drug Registration Approval
Time of Update: 2021-06-22
On June 15, Jingxin Pharmaceutical announced that it had recently received the "Drug Registration Certificate" for the chemical drug "Memantine Hydrochloride Sustained Release Capsules" [Specification 28mg] approved and issued by the State Food and Drug Administration .
-
FDA approves Biogen's new drug for Alzheimer's disease, provokes public outrage and 3 panelists resign
Time of Update: 2021-06-22
When the world boiled over when Biogen's new Alzheimer's drug Aduhelm was approved by the US Food and Drug Administration (FDA) for marketing, the three experts on the FDA's Expert Advisory Committee left their posts "angry" .
-
J Hepatology: Elevated bilirubin and alkaline phosphatase are associated with prolonged recovery time from drug-induced liver injury
Time of Update: 2021-06-10
Higher serum bilirubin and alkaline phosphatase (ALP) at the onset of DILI, longer onset time, and slower drug metabolism are associated with a longer recovery time from liver injury, and the researchers define it according to the score assigned by the model The high-risk and low-risk groups are selected.
